• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Entheon Biomedical Corp (OP: ENTBF )

    0.1030 +0.0146 (+16.52%)
    Streaming Delayed Price Updated: 10:24 AM EST, Nov 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Entheon Biomedical Corp

    < Previous 1 2 Next >
    World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
    The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business... 
    Via Benzinga
    PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate Its CYB004 Clinical Development Program
    Via Investor Brand Network
    PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study Expected to Accelerate Clinical Development Path of CYB004
    Via Investor Brand Network
    Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
    Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider. 
    Via Benzinga
    Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon & Cybin
    Cybin Inc. (NEO:CYBN) (NYSE American: CYBE) announced that, through its wholly-owned subsidiary Cybin IRL Limited, It has entered into an agreement to acquire a Phase 1 N,N-dimethyltryptamine (“DMT”)... 
    Via Benzinga
    Ehave Partners With Halugen Life Sciences To Create A Ketamine Precision Medicine Platform For Clinical Research
    Ehave, Inc. (OTC Pink: EHVVF) is a leading healthcare services and technology company focused on progressing psychedelics to therapeutics by engineering novel compounds and new treatment protocols for... 
    Via Benzinga
    Entheon Biomedical Announces Non-Brokered Private Placement Financing
    Entheon Biomedical Corp. (OTCQB: ENTBF) announced anon-brokered private placement financingfor up to 30,000,000 Units at ... 
    Via Benzinga
    Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
    The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,... 
    Via Benzinga
    Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins
    This week saw new triumphs for public companies in the psychedelics space with the creation of a new ETF tracking the sector, which went public in the NYSE. 
    Via Benzinga
    Psychedelics Biotech Startup Launches Phase 1 Study On Ayahuasca's Active Ingredient
    Psychedelics biotech startup Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) announced the approval by the local Dutch ethics committee for a Phase 1 clinical trial evaluating the pharmacokinetics,... 
    Via Benzinga
    Entheon Biomedical Reports Launching Multiple Studies to Advance Psychedelic-Based Mental Health Treatments
    Image provided by Flickr The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... 
    Via Benzinga
    Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) Featured in Virtual Coverage of Benzinga’s Small Cap Conference
    Via Investor Brand Network
    Compass Pathways 2.0: A New Rally In Psychedelic Stocks?
    Compass Pathways' IPO sparked a sector-wide rally in 2020. Now CMPS is on the move again. Is history about to repeat? 
    Via Talk Markets
    Topics Initial Public Offering
    Exposures Securities Market
    Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials
    Vancouver, British Columbia--(Newsfile Corp. - October 27, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or... 
    Via Newsfile
    Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
    The Week In Psychedelics 
    Via Benzinga
    Entheon Biomedical Acquires Lobo Genetics, Inc. in Bid to Strengthen Screening and Treatment Evaluation Tech for Psychedelics
    Image Provided by Wiki Commons Entheon Biomedical Corp. (OTCQB: ENTBF), the biotech research and development company focused on developing DMT-based treatments for addiction and... 
    Via Benzinga
    There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
    Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
    Via Benzinga
    Clinical Director of Imperial College's Center for Psychedelic Research Joins Entheon Advisory Board
    Vancouver, British Columbia--(Newsfile Corp. - August 25, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or... 
    Via Newsfile
    Entheon Biomedical Corp. Announces DTC Eligibility
    Vancouver, British Columbia--(Newsfile Corp. - August 24, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or... 
    Via Newsfile
    CORRECTION FROM SOURCE: BTV Examines the Rapidly Expanding Psychedelics Market
    Vancouver, British Columbia--(Newsfile Corp. - August 17, 2021) - On Sun. Aug. 22nd at 5pm EST broadcast on FOX Business... 
    Via Newsfile
    BTV Examines the Rapidly Expanding Psychedelics Market
    Vancouver, British Columbia--(Newsfile Corp. - August 17, 2021) - On Sun. Aug. 22nd at 5pm EST broadcast on FOX Business... 
    Via Newsfile
    Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Electroneurophysiologic Effects of Ketamine
    Vancouver, British Columbia--(Newsfile Corp. - August 12, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or... 
    Via Newsfile
    Exposures Product Safety
    Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected
    Last week in Psychedelics: 
    Via Benzinga
    Entheon Biomedical Corp. Strengthens Its Psychedelic-Assisted Protocols Through Acquisition Of Lobo Genetics
    Psychedelics biotech company Entheon Biomedical Corp. (CSE:ENBI 
    Via Benzinga
    Entheon Biomedical Corp. Acquires Lobo Genetics Inc.
    Vancouver, British Columbia--(Newsfile Corp. - July 30, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or... 
    Via Newsfile
    Topics Cannabis
    Exposures Cannabis
    Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Greenshaw
    Vancouver, British Columbia--(Newsfile Corp. - July 28, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or... 
    Via Newsfile
    How To Invest In "Magic Mushrooms" (Psychedelics)
    A look at psychedelics as stock market investment opportunities and identifying alternative strategies on how to invest. 
    Via Talk Markets
    Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies
    This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Ps... 
    Via Benzinga
    Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana
    Vancouver, British Columbia--(Newsfile Corp. - June 30, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or... 
    Via Newsfile
    Entheon Subsidiary, HaluGen Life Sciences, Partners with Maya Health to Drive Psychedelics Genetic Test Kit Awareness
    Vancouver, British Columbia--(Newsfile Corp. - June 25, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or... 
    Via Newsfile
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.